(Q44773060)

6 December 2017

title

Treatment-resistant bipolar disorder: a comparison of rapid cyclers and nonrapid cyclers (English)

1 reference

6 December 2017

1 reference

Dong Vo

1

1 reference

6 December 2017

David L Dunner

series ordinal

2

1 reference

6 December 2017

publication date

1 December 2003

1 reference

6 December 2017

1 reference

6 December 2017

volume

8

1 reference

6 December 2017

issue

12

1 reference

6 December 2017

page(s)

948-952

1 reference

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

Clinical Factors in Lithium Carbonate Prophylaxis Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

Clinical and differential diagnostic aspects of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

Extending indications for long-term pharmacotherapy: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

Treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

Patterns of treatment resistance in bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

Tranylcypromine versus imipramine in anergic bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

DSM-III-R personality disorders in a mood and anxiety disorders clinic: prevalence, comorbidity, and clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

7 January 2021

Lithium treatment and risk of suicidal behavior in bipolar disorder patients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

7 January 2021

Prophylaxis with lithium carbonate: an update

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

7 January 2021

A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

7 January 2021

A longitudinal investigation of lithium as a prophylactic agent for recurrent depressions

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

7 January 2021

Lithium carbonate prophylaxis of depression in three subtypes in primary affective disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

7 January 2021

Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

7 January 2021

Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900028716

7 January 2021

10.1017/S1092852900028716

Identifiers

DOI

1 reference

6 December 2017

1 reference